Coherus Oncology, Inc.
CHRS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001512762
No open-market purchases or sales by Coherus Oncology, Inc. insiders were filed in the last 90 days; 146 institutions reported holding it in 13F filings for Q2 2026, worth $98.5M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Coherus Oncology, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 135 | 2 | 128 | −5 |
| Shares | 82.6M | 11.8M | 76.9M | +6.15M (+8.7%) |
| Value | $142.9M | $20.4M | $79.9M | −$42.6M (−34.8%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Coherus Oncology, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 11,951,953 | $12.4M | 0.00% |
| ExodusPoint Capital Management, LP | 134,038 | $139.0K | 0.00% |
| State of Wyoming | 73,865 | $76.8K | 0.01% |
| Acadian Asset Management LLC | 56,445 | $58.0K | 0.00% |
| Cerity Partners LLC | 44,577 | $46.4K | 0.00% |
| Systematic Financial Management LP | 26,590 | $27.7K | 0.00% |
| Two Sigma Securities, LLC | 21,594 | $22.5K | 0.00% |
| Shell Asset Management Co | 17,554 | $18.0K | 0.00% |
| Wealth Enhancement Advisory Services, LLC | 15,633 | $16.3K | 0.00% |
| Engineers Gate Manager LP | 11,978 | $12.5K | 0.00% |
| Providence Wealth Advisors, LLC | 10,000 | $8.31K | 0.01% |
| True Wealth Design, LLC | 2,569 | $2.67K | 0.00% |
| Capital Performance Advisors LLP | 2,117 | $2.20K | 0.00% |
| Smartleaf Asset Management LLC | 880 | $924 | 0.00% |
| Federated Hermes, Inc. | 582 | $605 | 0.00% |
| Sterling Capital Management LLC | 288 | $300 | 0.00% |
| Allspring Global Investments Holdings, LLC | 100 | $104 | 0.00% |
Sold out (22)
Institutions that held Coherus Oncology, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Temasek Holdings (Private) Ltd | 5,818,802 | $10.1M |
| BIT Capital GmbH | 838,947 | $1.45M |
| Norges Bank | 491,500 | $850.3K |
| Marshall Wace, LLP | 420,326 | $727.2K |
| Wellington Management Group LLP | 369,702 | $639.6K |
| Woodline Partners LP | 322,680 | $558.2K |
| Pennant Investors, LP | 168,100 | $290.8K |
| Russell Investments Group, Ltd. | 72,955 | $126.2K |
| MetLife Investment Management | 62,706 | $108.5K |
| Brevan Howard Capital Management LP | 46,021 | $79.6K |
| Manufacturers Life Insurance Company, The | 44,645 | $77.2K |
| Savant Capital, LLC | 32,883 | $56.9K |
| Knights of Columbus Asset Advisors LLC | 30,922 | $53.5K |
| Walleye Capital LLC | 28,137 | $48.7K |
| Tiaa Trust, National Association | 27,261 | $47.2K |
| Dynamic Technology Lab Private Ltd | 19,556 | $34.0K |
| Principal Financial Group Inc | 17,372 | $30.1K |
| ELCO Management Co., LLC | 12,716 | $22.0K |
| Princeton Global Asset Management LLC | 10,474 | $18.1K |
| Squarepoint Ops LLC | 10,214 | $17.7K |
| nVerses Capital, LLC | 4,500 | $7.79K |
| Main Street Group, LTD | 200 | $322 |
Not filed for Q3 2024 yet (2)
Institutions that held Coherus Oncology, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 11,752,500 | $20.3M |
| Susquehanna Fundamental Investments, LLC | 36,748 | $63.6K |